Similarly caffeine, a non-specific inhibitor of ATM, is neuroprotective against etoposide-induced DNA damage to neurons in vitro (Kruman et al., 2004) and reducing ATM gene dosage is neuroprotective in a mouse model of Huntington’s disease (Lu et al., 2014). This evidence concerns the gene ATM and juvenile Huntington disease.